Month: March 2026

OMS Energy Technologies (NASDAQ: OMSE) Saudi Arabia Subsidiary Receives US$11 Million Call-Off Order from Saudi Aramco Under Long-Term Supply Agreement

Written by Customer Service on March 20, 2026. Posted in Public Companies.

Specialty Connector Order Under 10-Year Agreement Reinforces OMS Saudi’s Position as a Premier Regional Supplier Singapore, March 20, 2026 (GLOBE NEWSWIRE) — OMS Energy Technologies Inc. (“OMS” or the “Company”) (NASDAQ: OMSE), a growth-oriented manufacturer of surface wellhead systems (“SWS”) and oil country tubular goods (“OCTG”) for the oil and gas industry, today announced that its wholly-owned subsidiary, OMS Oilfield Services Arabia Ltd. (“OMS Saudi”), has received a US$11 million call-off order for specialty connectors and pipes under the Company’s existing long-term supply agreement with Saudi Aramco, the world’s largest oil producer. The products are expected to be delivered during calendar year 2026. The Company’s supply agreement with Saudi Aramco, signed in early 2024, operates on a call-off...

Aquestive Therapeutics Announces New Role of Lori J. Braender and Appointment of Thomas A. Zalewski as Chief Legal Officer and Chief Compliance Officer

Written by Customer Service on March 20, 2026. Posted in Public Companies.

Thomas A. Zalewski, a Partner at Day Pitney LLP, appointed Chief Legal Officer and Chief Compliance Officer effective April 2, 2026 Lori J. Braender to remain in a non-executive role as Corporate Secretary after nearly eight years as Chief Legal Officer, Chief Compliance Officer and Corporate SecretaryWARREN, N.J., March 20, 2026 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients’ lives through innovative science and delivery technologies, today announced the appointment of Thomas A. Zalewski as Chief Legal Officer and Chief Compliance Officer, effective April 2, 2026, succeeding Lori J. Braender, who will be stepping down as Chief Legal Officer and Chief Compliance...

WeShop Announces $2.0 Million Proceeds from the Exercise of Performance Incentive Grants

Written by Customer Service on March 20, 2026. Posted in Public Companies.

212,156 Performance Incentive Grants were exercised at $9.64 per share between January 30, 2026, and March 17, 2026, generating $2,045,184 in proceeds for WeShop Proceeds will support working capital and general corporate purposes as WeShop continues expansion across North AmericaLONDON, March 20, 2026 (GLOBE NEWSWIRE) — WeShop Holdings Limited (“WeShop” or the “Company”) (NASDAQ: WSHP), the world’s first community-owned social commerce platform, today announced that holders of the WeShop Performance Incentive Grants have exercised their grants to purchase the Company’s Class A ordinary shares. Since the listing on 14th November 2025, the holders of Performance Incentive Grants have exercised a total of 212,156 grants at $9.64 per share. These exercises generated aggregate proceeds to the Company of $2,045,184. The proceeds...

GigaCloud Technology Inc Announces Marketplace Initiative with Otto Group to Expand Assortment in Europe

Written by Customer Service on March 20, 2026. Posted in Public Companies.

EL MONTE, Calif., March 20, 2026 (GLOBE NEWSWIRE) — GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B ecommerce technology solutions for large parcel merchandise, today announced a marketplace initiative with Otto Group, one of Europe’s largest ecommerce and retail enterprises. As part of this initiative, GigaCloud will facilitate the introduction of select sellers, including leading furniture brands and suppliers, to Otto’s established European selling platform. The initiative is intended to broaden marketplace assortment while leveraging GigaCloud’s global supplier network and technology capabilities. “This collaboration aligns with our channel-agnostic strategy and reinforces our role as a marketplace solutions provider, connecting global supply with established selling...

Canterra Minerals Engages Atrium Research to Enhance Investor Visibility and Institutional Reach

Written by Customer Service on March 20, 2026. Posted in Public Companies.

VANCOUVER, British Columbia, March 20, 2026 (GLOBE NEWSWIRE) — Canterra Minerals Corporation (TSXV:CTM) (OTCQB: CTMCF) (FSE:DXZB) (“Canterra” or the “Company”) is pleased to announce it has engaged Atrium Research Corporation (“Atrium”), a prominent firm specializing in company-sponsored research, to support broader market awareness of Canterra’s exploration portfolio and ongoing 2026 drill programs. Atrium will be responsible for publishing various research reports on Canterra. These reports will be based on publicly available information, industry data, and direct discussions with the Company’s management and are expected to provide investors with detailed, third-party analysis of Canterra’s assets and exploration strategy. Additionally, Atrium will conduct and host two recorded interviews with Canterra’s...

Cardiff Oncology to Host Key Opinion Leader Discussion Focusing on First-Line RAS-mutated Metastatic Colorectal Cancer

Written by Customer Service on March 20, 2026. Posted in Public Companies.

SAN DIEGO, March 20, 2026 (GLOBE NEWSWIRE) — Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that the Company will host a key opinion leader (KOL) webinar to discuss the emergent treatment landscape in first-line RAS-mutated metastatic colorectal cancer (mCRC). The webinar will take place on Wednesday, March 25th, 2026, at 4:30 p.m. ET. The webinar will feature KOLs Scott Kopetz, M.D., Ph.D., FACP and Heinz-Josef Lenz, M.D., who will join Mani Mohindru, PhD, interim Chief Executive Officer, to discuss onvansertib’s existing clinical data and its potential as a novel therapeutic approach in the management of mCRC. About the KOLs Scott Kopetz, M.D., Ph.D., FACP, is a Professor in the Department of Gastrointestinal...

Aurora Mobile’s EngageLab Redefines Marketing Agility at MarketingPulse: Bridging AI Trends with Unified Execution

Written by Customer Service on March 20, 2026. Posted in Public Companies.

SINGAPORE, March 20, 2026 (GLOBE NEWSWIRE) — Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services, today announced that its AI-first customer engagement platform, EngageLab, successfully concluded its high-profile participation at Hong Kong MarketingPulse & eTailingPulse 2026, organized by HKTDC. Throughout the event at the HKCEC, EngageLab’s Booth became a premier destination for marketers seeking to “Redefine Customer Relationships for the AI Era.” Turning AI Trends into Marketing Reality MarketingPulse 2026 was abuzz with discussions on Agentic AI, reflecting a critical shift in the industry: marketers are no longer looking for simple automation, but for intelligent “agents” capable of autonomous reasoning...

Evidence of Efficacy and Safety of Deucrictibant for Prophylaxis and On-Demand Treatment of Hereditary Angioedema Attacks Published Back-to-Back in The Lancet Haematology

Written by Customer Service on March 20, 2026. Posted in Public Companies.

Results from Phase 2 clinical studies, CHAPTER-1 and RAPIDe-1, provide evidence of viability of bradykinin B2 receptor antagonism in management of HAEZUG, Switzerland, March 20, 2026 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema (HAE) and acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH), today announced that two articles have been published back-to-back in the same issue of The Lancet Haematology. The articles detail data from the two randomized Phase 2 studies, CHAPTER-1 and RAPIDe-1, evaluating the efficacy and safety of deucrictibant, a potent, orally bioavailable small-molecule bradykinin B2 receptor antagonist,...

BitFuFu Announces Unaudited 2025 Full-Year Financial Results

Written by Customer Service on March 20, 2026. Posted in Earnings Releases And Operating Results.

SINGAPORE, March 20, 2026 (GLOBE NEWSWIRE) — BitFuFu Inc. (“BitFuFu” or the “Company”) (NASDAQ: FUFU), a world-leading Bitcoin miner and mining services innovator, today announced its unaudited financial results for the full year ended December 31, 2025. Full Year 2025 Financial HighlightsTotal revenue was $475.8 million in 2025, representing an increase of 2.7% from $463.3 million in 2024. The year-over-year increase was driven by higher revenue from Cloud Mining Solutions, Mining Equipment Sales, and Other, partially offset by a decline in revenue from Self-Mining Operations. For the Year Ended December 31, 2025 2024Business Segment ($ in millions) Revenue % ofRevenue Revenue % ofRevenueCloud Mining Solutions $ 350.6 73.7 % $ 271.0 58.5 % Self-Mining Operations 63.1 13.3 % 157.5 34.0 % Mining...

The Ensign Group, Inc. Declares Quarterly Dividend of $0.0650 Per Share

Written by Customer Service on March 20, 2026. Posted in Dividend Reports And Estimates.

SAN JUAN CAPISTRANO, Calif., March 20, 2026 (GLOBE NEWSWIRE) — The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it has declared a quarterly cash dividend of $0.0650 per share of Ensign common stock, payable on or before April 30, 2026, to shareholders of record as of March 31, 2026. Ensign has been a dividend-paying company since 2002. About Ensign™ The Ensign Group, Inc.’s independent operating subsidiaries provide a broad spectrum of skilled nursing and senior living services, physical, occupational and speech therapies and other rehabilitative and healthcare services...

Month: March 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals